N
TNXP icon

Nuveen’s Tonix Pharmaceuticals TNXP Stock Holding History

Nuveen’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.3M Buy
94,561
+1,159
+1% +$17.8K ﹤0.01% 2466
2025
Q4 		$1.46M Buy
93,402
+78,033
+508% +$1.44M ﹤0.01% 2423
2025
Q3 		$371K Sell
15,369
-36,523
-70% -$1.36M ﹤0.01% 2993
2025
Q2 		$1.87M Buy
+51,892
New +$1.36M ﹤0.01% 2334
2022
Q2 		– Sell
-2
Closed -$315K – 3475
2022
Q1 		$315K Sell
2
-1
-33% -$153K ﹤0.01% 3116
2021
Q4 		$665K Hold
3
– – ﹤0.01% 2993
2021
Q3 		$1.07M Hold
3
– – ﹤0.01% 2969
2021
Q2 		$1.94M Buy
+3
New +$2.21M ﹤0.01% 2726

Other funds holding TNXP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Nuveen's TNXP Position: Q1 2026 in Review

Nuveen increased its Tonix Pharmaceuticals (TNXP) stake by 1.2% in Q1 2026, buying an estimated $17.8K and bringing the position to 94,561 shares worth $1.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2466.

Nuveen first reported a position in TNXP in Q2 2021 and has held it in 8 quarters since. The position peaked at $1.94M in Q2 2021. 81 funds tracked by Wall St. Rank hold TNXP as of Q1 2026.

  • Nuveen held 94,561 shares of Tonix Pharmaceuticals worth $1.3M as of Q1 2026.
  • Nuveen bought 1,159 Tonix Pharmaceuticals shares in Q1 2026, an estimated $17.8K.
  • Tonix Pharmaceuticals made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #2466 holding.
  • Nuveen first reported a position in Tonix Pharmaceuticals in Q2 2021 and has held it in 8 quarters since.
  • Nuveen's Tonix Pharmaceuticals position peaked at $1.94M in Q2 2021.
  • 81 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.